Interactions with Dietary Supplements
Glycine
Two double-blind studies have found that 0.4–0.8 mg/kg body weight per day of glycine can reduce the so-called negative symptoms of schizophrenia when combined with haloperidol and related drugs.1 2 Negative symptoms include reduced emotional expression or general activity. The action of glycine in combination with the drugs was greater than the drugs alone, suggesting a synergistic action. Another double-blind study using approximately half the amount in the positive studies could not find any benefit from adding glycine to anti-psychotic drug therapy.3 Patients with low blood levels of glycine appeared to improve the most when given glycine in addition to their anti-psychotic drugs.4 No side effects were noticed in these studies, even when more than 30 grams of glycine were given daily.
Iron
Haloperidol may cause decreased blood levels of iron.5 The importance of this interaction remains unclear. Iron should not be supplemented unless a deficiency is diagnosed.
Potassium
Haloperidol may cause hyperkalemia (high blood levels of potassium) or hypokalemia (low blood levels of potassium).6 The incidence and severity of these changes remains unclear. Serum potassium can be measured by any doctor.
Vitamin E
Haloperidol and related anti-psychotic drugs can cause a movement disorder called tardive dyskinesia. A few double-blind studies suggest that vitamin E may be beneficial for treatment of tardive dyskinesia.7 Taking the large amount of 1,600 IU per day of vitamin E simultaneously with anti-psychotic drugs has also been shown to lessen symptoms of tardive dyskinesia.8 It is unknown if combining vitamin E with haloperidol could prevent tardive dyskinesia.
Sodium
Haloperidol may cause hyponatremia (low blood levels of sodium).9 The incidence and severity of these changes remains unclear.
References
1. Heresco-Levy U, Javitt DC, Ermilov M, et al. Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 1996;169:610–7.
2. Javitt DC, Zylberman I, Zukin SR, et al. Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994;151:1234–6.
3. Potkin SG, Costa J, Roy S, et al. Glycine in treatment of schizophrenia—theory and preliminary results. In: Meltzer HY (ed). Novel Antipsychotic Drugs. New York: Raven Press, 1990:179–88.
4. Heresco-Levy U, Javitt DC, Ermilov M, et al. Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 1996;169:610–7.
5. Threlkeld DS, ed. Central Nervous System Drugs, Antipsychotic Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, May 1998, 266k–6m.
6. Threlkeld DS, ed. Central Nervous System Drugs, Antipsychotic Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, May 1998, 266k–6m.
7. Adler LA, Peselow E, Rotrosen J, et al. Vitamin E treatment of tardive dyskinesia. Am J Psychiatry 1993;150:1405–7.
8. Adler LA, Edson R, Lavori P, et al. Long-term treatment effects of vitamin E for tardive dyskinesia. Biol Psychiatry 1998;43:868–72.
9. Threlkeld DS, ed. Central Nervous System Drugs, Antipsychotic Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, May 1998, 266k–6m.
10. Palasciano G, Portincasa P, Palmieri V, et al. The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs. Curr Ther Res 1994;55:537–45.
11. Zhang XY, Zhou DF, Zhang PY, et al. A
double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. J Clin Psychiatry 2001;62:878–83.
12. Lasswell WL Jr, Weber SS, Wilkins JM. In vitro interaction of neuroleptics and tricyclic antidepressants with coffee, tea, and gallotannic acid. J Pharm Sci 1984;73:1056–8.
13. Threlkeld DS, ed. Central Nervous System Drugs, Antipsychotic Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, May 1998, 266k–6m.

Copyright © 2007 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Please read the disclaimer about the limitations of the information provided here. Do NOT rely solely on the information in this article.
Learn more about Healthnotes, the company.
Learn more about the authors of Using Medicines with Vitamins and Herbs
The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or chemist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires September 2008.